Kuta Alexander Edward III

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(8%)(9%)(2%)(1%)0%
Sale Success Rate4 of 212 of 213 of 214 of 210 of 21

Uniqure N.V.

Drugs » Biotechnology

Executive VP, Operations:

Holdings: 90.38K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--